On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction ...

In 2017 the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).

Bird & Bird has been ranked in 15 jurisdictions in the newly-launched IAM Patent Litigation 1000: The World's Leading Patent Litigators (Europe & Asia).

Asiantuntijoiden joukossa Ella Mikkola